Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 00887A204 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
BIOS Fund I, LP
13G/A
|
10.0% |
5/8/2026
Event 5/6/2026
|
||
| Bios Fund I, LP | 2.1% | |||
| Bios Capital Management, LP | 10.0% | |||
| Bios Fund II, LP | 0.5% | |||
| Bios Fund II QP, LP | 1.7% | |||
| Bios Fund II NT, LP | 0.2% | |||
| Bios Equity Partners, LP | 0% | |||
| Bios Clinical Opportunity Fund, LP | 3.0% | |||
| Bios Fund III QP, LP | 1.7% | |||
| Bios Fund III NT, LP | 0.3% | |||
| Bios Advisors GP, LLC | 10.0% | |||
| Bios Fund III, LP | 0.3% | |||
| Bios Equity Cof, LP | 2.2% | |||
| Bios Equity Partners II, LP | 2.4% | |||
| Bios Equity Partners III, LP | 2.2% | |||
| Cavu Advisors, LLC | 10.0% | |||
| Cavu Management, LP | 10.0% | |||
| Leslie W. Kreis | 10.0% | |||
| Aaron G.L. Fletcher | 10.0% | |||
| Bios Fund I QP, LP | 1.2% | |||
| Bios LTI Co-Invest III QP, LP | 5.5% | |||
| Bios LTI Co-Invest III, LP | 5.4% | |||
| Bios LTI SPV II, LP | 1.9% | |||
| Bios 2026 Co-Invest, LP | 1.3% | |||
| Bios 2024 Co-Invest, LP | 0.7% | |||
|
Funicular Funds, LP
13G
|
6.7% |
5/7/2026
Event 5/1/2026
|
||
| Funicular Funds, LP | 6.7% | |||
| Cable Car Capital, LP | 6.7% | |||
| Ma-Weaver Jacob | 6.7% | |||
|
Voss Capital, LP
13G/A
|
6.6% |
7/14/2026
Event 6/30/2026
|
||
| Voss Value Master Fund, LP | 1.2% | |||
| Voss Value-Oriented Special Situations Fund, LP | 0.6% | |||
| Voss Advisors GP, LLC | 1.8% | |||
| Voss Capital, LP | 6.6% | |||
| Cocke Travis W. | 6.6% | |||
|
ADAR1 Capital Management, LLC
13G
|
5.3% |
8/14/2026
Event 6/30/2026
|
||
| ADAR1 Capital Management, LLC | 5.3% | |||
| Daniel Schneeberger | 5.3% | |||
|
Lynwood Capital Management Inc.
13G/A
|
5.0% |
8/14/2026
Event 6/30/2026
|
||
| Lynwood Capital Management Inc. | 5.0% | |||
| Ben Shapiro | 5.0% | |||
| Lynwood Opportunities Master Fund | 5.0% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (3) | ||||
|
BIOS Fund III, LP
13G
|
6.2% |
8/11/2025
Event 5/5/2025
|
||
| Bios Fund III, LP | 0.7% | |||
| Bios Fund III QP, LP | 4.7% | |||
| Bios Fund III NT, LP | 0.8% | |||
| Bios Equity Partners III, LP | 6.2% | |||
| Cavu Management, LP | 6.2% | |||
| Bios Capital Management, LP | 6.2% | |||
| Cavu Advisors, LLC | 6.2% | |||
| Bios Advisors GP, LLC | 6.2% | |||
| Leslie Wayne Kreis, Jr. | 6.2% | |||
| Aaron Glenn Louis Fletcher | 6.2% | |||
| Lytton Laurence W 13G/A | 4.9% |
8/13/2026
Event 6/30/2026
|
||
|
University of Texas/Texas Am Investment Management Co
13G/A
|
4.4% |
11/5/2024
Event 11/4/2024
|
||
| University of Texas/Texas Am Investment Management Co | 4.4% | |||
| The Board of Regents of the University of Texas System | 4.4% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 4 | 42.5 k | $34.2 k |
| 2026 Q2 | 60 | 40.9 M | $42.5 M |
| 2026 Q1 | 46 | 11.4 M | $14.8 M |
| 2025 Q4 | 48 | 10.8 M | $12.5 M |
| 2025 Q3 | 40 | 8.49 M | $9.76 M |
| 2025 Q2 | 37 | 6.66 M | $9.54 M |
| 2025 Q1 | 40 | 6.02 M | $10.6 M |
| 2024 Q4 | 32 | 5.68 M | $13.1 M |
| 2024 Q3 | 32 | 4.61 M | $16.3 M |
| 2024 Q2 | 32 | 7.14 M | $19.7 M |
| 2024 Q1 | 26 | 1.69 M | $11.0 M |
| 2023 Q4 | 22 | 1.06 M | $3.25 M |
| 2023 Q3 | 17 | 1.05 M | $1.59 M |
| 2023 Q2 | 18 | 1.02 M | $1.83 M |
| 2023 Q1 | 20 | 1.05 M | $1.30 M |
| 2022 Q4 | 20 | 1.36 M | $3.21 M |